Cardiac protection by pharmacological modulation of inflammation

R. Latini, S. Masson, R. Bertini, A. P. Maggioni, P. Ghezzi, L. Calvillo

Research output: Contribution to journalArticlepeer-review

Abstract

Inflammation is a reaction to primary injury of various kinds, such as infection and trauma, which has both beneficial and detrimental effects. Inflammation has been associated with major diseases of the heart and vessels. Research has focused not only on ischaemia but also on post-ischaemic reperfusion, which is known to activate and amplify the inflammatory response. Although reperfusion should always be attempted in the clinical environment, it has been shown experimentally that it can cause some cardiac damage, in addition to that caused by ischaemia. Therefore, it is reasonable to attempt to increase the benefit obtainable with reperfusion by modulating inflammatory processes triggered by reperfusion itself. In this field, different potential therapeutic targets have been identified and interventions have been tested over the last 30 years. With the exception of adenosine, which probably does not act merely through inhibition of the inflammatory response, no other compounds have yet proven successful in clinical trials. Active research is ongoing. Broadening the approach from the heart to the cardiovascular system, promising data is emerging on cardiovascular protection conferred by statins in patients with coronary heart disease (CHD) and high levels of C-reactive protein (CRP), a systemic marker of inflammation. Similarly, results of trials aimed at preventing cardiovascular events by eradicating chronic infections will be among the first to directly test whether such therapies will decrease risks of cardiovascular disease.

Original languageEnglish
Pages (from-to)1913-1924
Number of pages12
JournalExpert Opinion on Investigational Drugs
Volume10
Issue number11
DOIs
Publication statusPublished - 2001

Keywords

  • Adenosine
  • Antibiotics
  • Atherosclerosis
  • Chemokines
  • Cytokines
  • Inflammation
  • Myocardial ischaemia
  • Neutrophils
  • PMN
  • Reperfusion
  • Strains

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Cardiac protection by pharmacological modulation of inflammation'. Together they form a unique fingerprint.

Cite this